Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
124.03
+19.09 (18.19%)
Aug 25, 2026, 3:40 PM EDT - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.83 billion as of August 25, 2026. Its market cap has increased by 404.05% in one year.
Market Cap
1.83B
Enterprise Value
1.87B
1-Year Change
404.05%
Ranking
Category
Stock Price
$124.03
ChartMarket Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.83B, an increase of 820.79%. That is a compound annual growth rate of 169.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.83B | 58.87% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.58B |
| Ascentage Pharma Group International | 1.56B |
| Tyra Biosciences | 1.55B |
| Apnimed | 1.55B |
| First Tracks Biotherapeutics | 1.54B |
| LB Pharmaceuticals | 1.54B |
| Innoviva | 1.52B |
| SL Science Holding | 1.51B |